These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
¨
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
¨
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
U.S. GAAP
x
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board
o
|
Other
o
|
|
|
Ÿ
|
statements regarding the expected growth in the use of particular broadband applications;
|
|
|
Ÿ
|
statements as to our ability to meet anticipated cash needs based on our current business plan;
|
|
|
Ÿ
|
statements as to the impact of the rate of inflation and the political and security situation on our business;
|
|
|
Ÿ
|
statements regarding auction-rate securities and their expected impact on our liquidity;
|
|
|
Ÿ
|
statements regarding the price and market liquidity of our ordinary shares;
|
|
|
Ÿ
|
statements as to our ability to retain our current suppliers and subcontractors;
|
|
|
Ÿ
|
statements regarding our future performance, sales, gross margins, expenses (including stock-based compensation expenses) and cost of revenues; and
|
|
|
Ÿ
|
statements regarding whether we will be classified as a passive foreign investment company.
|
| Page | ||
|
Part I
|
||
|
1
|
||
|
1
|
||
|
1
|
||
|
Selected Financial Data
|
1
|
|
|
Risk Factors
|
3
|
|
|
21
|
||
|
History and Development of Allot
|
21
|
|
|
Business Overview
|
21
|
|
|
Organizational Structure
|
31
|
|
|
Property, Plants and Equipment
|
31
|
|
|
32
|
||
|
32
|
||
|
Operating Results
|
32
|
|
|
Liquidity and Capital Resources
|
48
|
|
|
Research and Development, Patents and Licenses
|
50
|
|
|
Trend Information
|
50
|
|
|
Off-Balance Sheet Arrangements
|
50
|
|
|
Contractual Obligations
|
50
|
|
|
51
|
||
|
Directors and Senior Management
|
51
|
|
|
Compensation of Officers and Directors
|
55
|
|
|
Board Practices
|
56
|
|
|
Employees
|
64
|
|
|
Share Ownership
|
64
|
|
|
68
|
||
|
Major Shareholders
|
68
|
|
|
Related Party Transactions
|
70
|
|
|
73
|
||
|
Consolidated Financial Statements and Other Financial Information
|
73
|
|
|
Significant Changes
|
74
|
|
|
74
|
||
|
Stock Price History
|
74
|
|
|
Markets
|
75
|
|
|
75
|
||
|
Memorandum of Association and Amended and Restated Articles of Association
|
75
|
|
|
Material Contracts
|
78
|
|
|
Exchange Controls
|
78
|
|
|
Taxation
|
79
|
|
|
Documents on Display
|
93
|
|
|
94
|
||
|
95
|
|
Part II
|
||
|
95
|
||
|
95
|
||
|
96
|
||
|
97
|
||
|
97
|
||
|
97
|
||
|
97
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
Part III
|
||
|
99
|
||
|
99
|
||
|
99
|
|
Year ended December 31,
|
||||||||||||||||||||
|
2005
|
2006
|
2007
|
2008
|
2009
|
||||||||||||||||
|
(in thousands of U.S. dollars, except per share and share data)
|
||||||||||||||||||||
|
Consolidated Statements of Operations:
|
||||||||||||||||||||
|
Revenues:
|
||||||||||||||||||||
|
Products
|
$ | 18,498 | $ | 28,756 | $ | 25,073 | $ | 27,121 | $ | 29,641 | ||||||||||
|
Services
|
4,474 | 5,388 | 7,429 | 9,980 | 12,110 | |||||||||||||||
|
Total revenues
|
22,972 | 34,144 | 32,502 | 37,101 | 41,751 | |||||||||||||||
|
Cost of revenues(1):
|
||||||||||||||||||||
|
Products
|
4,481 | 6,435 | 6,603 | 8,198 | 10,094 | |||||||||||||||
|
Services
|
938 | 1,162 | 1,416 | 1,498 | 1,741 | |||||||||||||||
|
Total cost of revenues
|
5,419 | 7,597 | 8,019 | 9,696 | 11,835 | |||||||||||||||
|
Gross profit
|
17,553 | 26,547 | 24,483 | 27,405 | 29,916 | |||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||
|
Research and development, gross
|
6,652 | 9,340 | 11,755 | 14,635 | 11,705 | |||||||||||||||
|
Less royalty-bearing participation
|
727 | 1,811 | 2,371 | 2,671 | 2,440 | |||||||||||||||
|
Research and development, net(1)
|
5,925 | 7,529 | 9,384 | 11,964 | 9,265 | |||||||||||||||
|
Sales and marketing(1)
|
11,887 | 15,457 | 18,081 | 19,781 | 20,408 | |||||||||||||||
|
General and administrative(1)
|
2,380 | 3,464 | 5,583 | 6,174 | 5,541 | |||||||||||||||
|
In process research and development
|
- | - | - | 244 | - | |||||||||||||||
|
Total operating expenses
|
20,192 | 26,450 | 33,048 | 38,163 | 35,214 | |||||||||||||||
|
Operating income (loss)
|
(2,639 | ) | 97 | (8,565 | ) | (10,758 | ) | (5,298 | ) | |||||||||||
|
Financing and other income (expenses), net
|
45 | 630 | (845 | ) | (5,517 | ) | (2,311 | ) | ||||||||||||
|
Income (loss) before income tax expenses (benefit)
|
(2,594 | ) | 727 | (9,410 | ) | (16,275 | ) | (7,609 | ) | |||||||||||
|
Income tax expenses (benefit)
|
(218 | ) | 111 | 530 | 220 | 63 | ||||||||||||||
|
Net income (loss)
|
$ | (2,376 | ) | $ | 616 | $ | (9,940 | ) | $ | (16,495 | ) | $ | (7,672 | ) | ||||||
|
Basic and diluted net earnings (loss) per share
|
$ | (0.81 | ) | $ | 0.04 | $ | (0.46 | ) | $ | (0.75 | ) | $ | (0.35 | ) | ||||||
|
Weighted average number of shares used in computing basic net earnings (loss) per share
|
2,943,500 | 14,402,338 | 21,525,822 | 22,054,211 | 22,185,702 | |||||||||||||||
|
Weighted average number of shares used in computing diluted net earnings (loss) per share
|
2,943,500 | 16,423,227 | 21,525,822 | 22,054,211 | 22,185,702 |
|
(1)
|
Includes stock-based compensation expense related to options granted to employees and others as follows:
|
|
Year ended December 31,
|
||||||||||||||||||||
|
2005
|
2006
|
2007
|
2008
|
2009
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Cost of revenues
|
$ | — | $ | 15 | $ | 48 | $ | 50 | $ | 104 | ||||||||||
|
Research and development expenses, net
|
12 | 157 | 230 | 321 | 357 | |||||||||||||||
|
Sales and marketing expenses
|
251 | 650 | 340 | 465 | 775 | |||||||||||||||
|
General and administrative expenses
|
42 | 539 | 743 | 866 | 1,062 | |||||||||||||||
|
Total
|
$ | 305 | $ | 1,361 | $ | 1,361 | $ | 1,702 | $ | 2,298 | ||||||||||
|
At December 31,
|
||||||||||||||||||||
|
2005
|
2006
|
2007
|
2008
|
2009
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Consolidated balance sheet data:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
$ | 3,677 | $ | 7,117 | $ | 28,101 | $ | 40,029 | $ | 36,470 | ||||||||||
|
Marketable securities
|
4,581 | 76,114 | 42,614 | 15,319 | 14,490 | |||||||||||||||
|
Working capital
|
4,274 | 75,182 | 37,225 | 40,688 | 38,179 | |||||||||||||||
|
Total assets
|
17,591 | 99,506 | 94,655 | 82,851 |
82,943
|
|||||||||||||||
|
Total liabilities
|
11,465 | 15,319 | 17,470 | 19,672 |
22,531
|
|||||||||||||||
|
Accumulated deficit
|
(37,884 | ) | (37,268 | ) | (47,208 | ) | (63,703 | ) | (63,694 | ) | ||||||||||
|
Total shareholders’ equity
|
6,126 | 84,187 | 77,185 | 63,179 | 60,412 | |||||||||||||||
|
|
Ÿ
|
substantial cash expenditures;
|
|
|
Ÿ
|
potentially dilutive issuances of equity securities;
|
|
|
Ÿ
|
the incurrence of debt and contingent liabilities;
|
|
|
Ÿ
|
a decrease in our profit margins; and
|
|
|
Ÿ
|
amortization of intangibles and potential impairment of goodwill.
|
|
|
Ÿ
|
current or future U.S. or foreign patents applications will be approved;
|
|
|
Ÿ
|
our issued patents will protect our intellectual property and not be held invalid or unenforceable if challenged by third parties;
|
|
|
Ÿ
|
we will succeed in protecting our technology adequately in all key jurisdictions in which we or our competitors operate;
|
|
|
Ÿ
|
the patents of others will not have an adverse effect on our ability to do business; or
|
|
|
Ÿ
|
others will not independently develop similar or competing products or methods or design around any patents that may be issued to us.
|
|
|
Ÿ
|
announcements or introductions of technological innovations or new products, or product enhancements or pricing policies by us or our competitors;
|
|
|
Ÿ
|
disputes or other developments with respect to our or our competitors’ intellectual property rights;
|
|
|
Ÿ
|
announcements of strategic partnerships, joint ventures or other agreements by us or our competitors;
|
|
|
Ÿ
|
recruitment or departure of key personnel;
|
|
|
Ÿ
|
regulatory developments in the markets in which we sell our products;
|
|
|
Ÿ
|
our sale of ordinary shares or other securities in the future;
|
|
|
Ÿ
|
changes in the estimation of the future size and growth of our markets;
|
|
|
Ÿ
|
market conditions in our industry, the industries of our customers and the economy as a whole; or
|
|
|
Ÿ
|
implementation of a share buyback plan.
|
|
|
Ÿ
|
the composition of our board of directors which has the authority to direct our business and to appoint and remove our officers;
|
|
|
Ÿ
|
approving or rejecting a merger, consolidation or other business combination;
|
|
|
Ÿ
|
raising future capital; and
|
|
|
Ÿ
|
amending our articles of association which govern the rights attached to our ordinary shares.
|
|
Series
|
Target Market
|
Operation Speeds
|
Subscribers(1)
|
|||
|
NetEnforcer AC-400
|
Small to medium enterprise networks and service provider networks
|
Up to 200 Mbps
|
Up to 4,000
|
|||
|
NetEnforcer AC-800
|
Medium and large enterprise networks and medium service provider networks
|
Up to 620 Mbps
|
Up to 28,000
|
|||
|
NetEnforcer AC-1000/ AC-2500
|
Carrier-class solutions used by medium and large service provider networks
|
Up to 2 Gbps and 5 Gbps, respectively
|
Up to 80,000
|
|||
|
NetEnforcer AC-1400/ AC-3000
|
Carrier-class solutions used by large enterprise networks and medium and large service provider networks
|
Up to 2 Gbps and 8 Gbps, respectively
|
160,000
|
|||
|
NetEnforcer AC-5000
|
Carrier-class solutions used by medium and large service provider networks with 1G and 10GE networks
|
Up to 15 Gbps
|
400,000
|
|||
|
NetEnforcer AC-10000
|
Carrier-class solutions used by medium and large service provider networks with 1G and 10GE networks
|
Up to 30 Gbps
|
Up to 800,000
|
|||
|
Service Gateway – Omega/Sigma
|
Carrier-class solutions used by medium and large service provider networks
|
Up to 60 Gbps
|
Up to 2,000,000
|
|
(1)
|
Represents the maximum number of subscribers that a system can handle simultaneously. Typically, due to network topology, redundancy requirements and other constraints, such as total bandwidth available per subscriber, the actual number per product unit is lower
|
|
|
Ÿ
|
expedited replacement units in the event of a warranty claim; and
|
|
|
Ÿ
|
software updates and upgrades offering new features and addressing new network applications.
|
|
Year Ended December 31,
|
||||||||||||
|
2007
|
2008
|
2009
|
||||||||||
|
United States
|
20 | 21 | 15 | |||||||||
|
Europe
|
33 | 33 | 45 | |||||||||
|
Asia and Oceania
|
30 | 30 | 26 | |||||||||
|
Middle East and Africa
|
6 | 7 | 7 | |||||||||
|
Americas (excluding United States)
|
11 | 9 | 7 | |||||||||
|
Total
|
100 | % | 100 | % | 100 | % | ||||||
|
|
●
|
Revenue Recognition
|
|
|
●
|
Allowance for Doubtful Accounts
|
|
|
●
|
Stock Based Compensation
|
|
|
●
|
Inventories
|
|
|
●
|
Marketable Securities
|
|
|
●
|
Impairment of Goodwill and other Long Lived Assets
|
|
|
●
|
Contingencies
|
|
|
●
|
provide updated guidance on whether multiple deliverables exist, how the deliverables in an arrangement should be separated, and how the consideration should be allocated;
|
|
|
●
|
require an entity to allocate revenue in an arrangement using estimated selling prices (“ESP”) of deliverables if a vendor does not have vendor-specific objective evidence of selling price (“VSOE”) or third-party evidence of selling price (“TPE”); and
|
|
|
●
|
eliminate the use of the residual method and require an entity to allocate revenue using the relative selling price method.
|
|
|
●
|
require expanded disclosures of qualitative and quantitative information regarding application of the multiple-deliverable revenue arrangement guidance.
|
|
Year ended December 31,
|
||||||||||||
|
2007
|
2008
|
2009
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
77.1 | % | 73.1 | % | 71.0 | % | ||||||
|
Services
|
22.9 | 26.9 | 29.0 | |||||||||
|
Total revenues
|
100.0 | 100.0 | 100.0 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
20.3 | 22.1 | 24.2 | |||||||||
|
Services
|
4.4 | 4 | 4.2 | |||||||||
|
Total cost of revenues
|
24.7 | 26.1 | 28.4 | |||||||||
|
Gross profit
|
75.3 | 73.9 | 71.6 | |||||||||
|
Operating expenses
:
|
||||||||||||
|
Research and development, net
|
28.9 | 32.2 | 22.1 | |||||||||
|
Sales and marketing
|
55.6 | 53.3 | 48.9 | |||||||||
|
General and administrative
|
17.2 | 16.6 | 13.3 | |||||||||
|
In Process Research and Development
|
- | 0.7 | - | |||||||||
|
Total operating expenses
|
101.7 | 102.8 | 84.3 | |||||||||
|
Operating loss
|
(26.4 | ) | (28.9 | ) | (12.7 | ) | ||||||
|
Financing and other income (expenses), net
|
(2.6 | ) | (14.9 | ) | (5.5 | ) | ||||||
|
Loss before income tax benefit (expense)
|
(29.0 | ) | (43.9 | ) | (18.2 | ) | ||||||
|
Income tax expense
|
1.6 | 0.6 | 0.1 | |||||||||
|
Net income (loss)
|
(30.6 | ) | (44.5 | ) | (18.3 | ) | ||||||
|
Payments due by period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than 1 year
|
1– 3 years
|
3-5 years
|
Over 5 years
|
|||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Operating leases — offices(1)
|
$ | 3,447 | $ | 1,043 | $ | 1,705 | $ | 699 | $ | - | ||||||||||
|
Operating leases — vehicles
|
144 | 79 | 65 | - | - | |||||||||||||||
|
Purchase obligations
|
1.800 | 1,800 | - | - | - | |||||||||||||||
|
Accrued severance pay(2)
|
3,364 | - | - | - | 3,364 | |||||||||||||||
|
Other(3)
|
75 | 75 | - | - | - | |||||||||||||||
|
Total
|
$ | 8.830 | $ | 2,997 | $ | 1,770 | $ | 699 | $ | 3,364 | ||||||||||
|
(1)
|
Consists primarily of an operating lease for our facilities in Hod-Hasharon, Israel, as well as operating leases for facilities leased by our subsidiaries.
|
|
(2)
|
Accrued severance pay relates to obligations to our Israeli employees as required under Israeli labor laws.
|
|
(3)
|
Exposure associated with tax position for current year.
|
|
Name
|
Age
|
Position
|
||
|
Directors
|
||||
|
Shraga Katz
|
57
|
Chairman of the Board
|
||
|
Rami Hadar
|
46
|
Director, Chief Executive Officer and President
|
||
|
Dr. Eyal Kishon(1)(2)
|
50
|
Director
|
||
|
Nurit Benjamini(1)(2)
|
43
|
Director
|
||
|
Shai Saul(1)
|
48
|
Director
|
||
|
Steven D. Levy(2)
|
53
|
Director
|
||
|
Yigal Jacoby
|
49
|
Director
|
||
|
Executive Officers
|
||||
|
Amir Hochbaum
|
50
|
Vice President — Research and Development
|
||
|
Anat Shenig
|
40
|
Vice President — Human Resources
|
||
|
Andrei Elefant
|
36
|
Vice President — Product Management and Marketing
|
||
|
Doron Arazi(3)
|
46
|
Chief Financial Officer
|
||
|
Eli Cohen
|
41
|
Vice President — International Sales
|
||
|
Jay Klein
|
46
|
Vice President — Chief Technology Officer
|
||
|
Lior Moyal
|
38
|
Vice President — Business Development
|
||
|
Pini Gvili
|
44
|
Vice President — Operations
|
||
|
Ramy Moriah
|
54
|
Vice President — Customer Care and Information Technology
|
||
|
Vin Costello
|
52
|
Vice President and General Manager — The Americas
|
|
|
Ÿ
|
an employment relationship;
|
|
|
Ÿ
|
a business or professional relationship maintained on a regular basis;
|
|
|
Ÿ
|
control; and
|
|
|
Ÿ
|
service as an office holder, excluding service as a director in a private company prior to the first offering of its shares to the public if such director was appointed as a director of the private company in order to serve as an outside director following the public offering.
|
|
|
Ÿ
|
the majority of shares voted at the meeting, including at least one-third of the shares of non-controlling shareholders voted at the meeting, excluding abstentions, vote in favor of the election of the outside director; or
|
|
|
Ÿ
|
the total number of shares of non-controlling shareholders
voted against the election of the outside director does not exceed one percent of the aggregate voting rights in the company.
|
|
|
Ÿ
|
chairman of the board of directors;
|
|
|
Ÿ
|
controlling shareholder or a relative of a controlling shareholder; and
|
|
|
Ÿ
|
any director employed by the company or who provides services to the company on a regular basis.
|
|
|
Ÿ
|
retaining and terminating the company’s independent auditors, subject to shareholder ratification;
|
|
|
Ÿ
|
pre-approval of audit and non-audit services provided by the independent auditors; and
|
|
|
Ÿ
|
approval of transactions with office holders and controlling shareholders, as described above, and other related-party transactions.
|
|
|
Ÿ
|
determining the compensation of our Chief Executive Officer and other executive officers;
|
|
|
Ÿ
|
granting options to our employees and the employees of our subsidiaries;
|
|
|
Ÿ
|
recommending candidates for nomination as members of our board of directors; and
|
|
|
Ÿ
|
developing and recommending to the board corporate governance guidelines and a code of business ethics and conduct in accordance with applicable laws.
|
|
|
Ÿ
|
reasonable litigation expenses, including attorneys’ fees, incurred by the office holder as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and
|
|
|
Ÿ
|
reasonable litigation expenses, including attorneys’ fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a third party or in connection with criminal proceedings in which the office holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent.
|
|
|
Ÿ
|
a breach of duty of loyalty to the company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
|
Ÿ
|
a breach of duty of care to the company or to a third party, including a breach arising out of the negligent conduct of the office holder; and
|
|
|
Ÿ
|
a financial liability imposed on the office holder in favor of a third party.
|
|
|
Ÿ
|
a breach of duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
|
Ÿ
|
a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
|
|
Ÿ
|
an act or omission committed with intent to derive illegal personal benefit; or
|
|
|
Ÿ
|
a fine or forfeit levied against the office holder.
|
|
December 31,
|
||||||||||||
|
Department
|
2007
|
2008
|
2009
|
|||||||||
|
Manufacturing and operations
|
16 | 16 | 16 | |||||||||
|
Research and development
|
92 | 94 | 92 | |||||||||
|
Sales, marketing, service and support
|
102 | 102 | 114 | |||||||||
|
Management and administration
|
32 | 31 | 30 | |||||||||
|
Total
|
242 | 243 | 252 | |||||||||
|
Name of Beneficial Owner
|
Number of Shares
Beneficially Held(1)
|
Percent of Class
|
||||||
|
Directors
|
||||||||
|
Shai Saul(2)
|
2,354,093
|
10.4
|
% | |||||
|
Yigal Jacoby(3)
|
1,524,431
|
6.6
|
% | |||||
|
Rami Hadar
|
553,427
|
2.4 | % | |||||
|
Eyal Kishon
|
* | * | ||||||
|
Nurit Benjamini
|
* | * | ||||||
|
Shraga Katz
|
* | * | ||||||
|
Steven D. Levy
|
* | * | ||||||
|
Executive Officers
|
||||||||
|
Amir Hochbaum
|
* | * | ||||||
|
Anat Shenig
|
* | * | ||||||
|
Andrei Elefant
|
* | * | ||||||
|
Doron Arazi
|
* | * | ||||||
|
Eli Cohen
|
* | * | ||||||
|
Jay Klein
|
* | * | ||||||
|
Lior Moyal
|
* | * | ||||||
|
Pini Gvili
|
* | * | ||||||
|
Ramy Moriah
|
* | * | ||||||
|
Vin Costello
|
* | * | ||||||
|
All directors and executive officers as a group
|
4,887,866
|
21.5
|
% | |||||
|
*
|
Less than one percent of the outstanding ordinary shares.
|
|
(1)
|
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from April 1, 2010 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 22,551,520 ordinary shares outstanding as of April 1, 2010.
|
|
(2)
|
Consists of 2,331,593 shares held by the Tamir Fishman Ventures and options to purchase 22,500 shares held by Shai Saul. Mr. Saul is a managing partner of Tamir Fishman and, by virtue of his position, may be deemed to have voting and investment power, and thus beneficial ownership, with respect to the shares held by the Tamir Fishman Ventures. Mr. Saul disclaims such beneficial ownership except to the extent of his pecuniary interest therein.
|
|
(3)
|
Consists of 835,410 shares held by Odem Rotem Holdings Ltd., a company wholly-owned and controlled by Yigal Jacoby, 58,548 shares jointly held by Yigal Jacoby and his spouse, Anat Jacoby, and an option to purchase 380,994 shares held by Odem Rotem Holdings. Also consists of a right held by Mr. Jacoby to purchase 246,479 shares currently held by a trustee. See “ITEM 7: Major Shareholders and Related Party Transactions—Related Party Transactions—Escrow Agreement with Yigal Jacoby.”
|
|
Ordinary Shares
Beneficially Owned(1)
|
Percentage of Ordinary Shares Beneficially Owned
|
|||||||
|
Brookside Capital Fund(2)
|
3,426,638 | 15.2 | % | |||||
|
Tamir Fishman Ventures(3)
|
2,354,093 | 10.4 | % | |||||
|
Zohar Zisapel(4)
|
2,292,319 | 10.2 | % | |||||
|
Diker Management(5)
|
2,160,061 | 9.6 | % | |||||
|
Yigal Jacoby(6)
|
1,524,431 | 6.6 | % | |||||
|
Gemini Group(7)
|
1,702,679 | 7.6 | % | |||||
|
(1)
|
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from April 1, 2010 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 22,551,520 ordinary shares outstanding as of April 1, 2010.
|
|
(2)
|
Based on a Schedule 13G/A filed on February 16, 2010. Consists of 3,426,638 shares held by Brookside Capital Partners Fund, L.P., a Delaware limited partnership. Brookside Capital Investors, L.P., a Delaware limited partnership is the sole general partner of the Brookside Capital Partners Fund, L.P. Brookside Capital Management, LLC, a Delaware limited liability company, is the sole general partner of Brookside Capital Investors, L.P. Domenic J. Ferrante is the sole managing member of Brookside Capital Management, LLC. The address of the Brookside entities and the foregoing individual is 111 Huntington Avenue, Boston, Massachusetts 02199.
|
|
(3)
|
Based on a Schedule 13G/A filed on February 14, 2008. Consists of 1,165,014 shares held by Tamir Fishman Ventures II L.P., 804,842 shares held by Tamir Fishman Venture Capital II Ltd., 155,904 shares held by Tamir Fishman Ventures II (Israel) L.P., 138,310 shares held by Tamir Fishman Ventures II (Cayman Islands) L.P., 54,543 shares held by Tamir Fishman Ventures II CEO Funds (U.S.) L.P., 12,980 shares held by Tamir Fishman Ventures II CEO Funds L.P. and an option to purchase 22,500 shares held by Shai Saul. Tamir Fishman Ventures II, LLC is the sole general partner of each of the foregoing limited partnerships and has management rights over the shares held by Tamir Fishman Venture Capital II Ltd. by virtue of a management agreement with Tamir Fishman Ventures II, LLC. The managing members of Tamir Fishman Ventures II, LLC are Shai Saul, Michael Elias and Tamir Fishman & Co. Ltd. Eldad Tamir and Danny Fishman are Co-Presidents and Co-Chief Executive Officers of Tamir Fishman & Co. Ltd. and, by virtue of their positions, may be deemed to be beneficial owners of the securities held thereby. Each of the foregoing entities and individuals disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein. The address of the Tamir Fishman entities and the foregoing individuals is 21 Haarbaa, Tel Aviv 64739 Israel.
|
|
(4)
|
Based on a Schedule 13G/A filed on March 30, 2009. Consists of 2,227,428 shares are held by Zohar Zisapel and 64,891 shares are held by Lomsha Ltd., an Israeli company controlled by Zohar Zisapel. The address of Mr. Zisapel and Lomsha Ltd. is 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel.
|
|
(5)
|
Based on a Schedule 13G filed on February 16, 2010. The address of Diker Management, LLC is 745 Fifth Avenue, Suite 1409, New York, New York 10151.
|
|
(6)
|
Based on a Schedule 13G/A filed on February 4, 2010 and to the Company’s best knowledge. Consists of 58,528 ordinary shares held jointly by Yigal Jacoby and his wife, Anat Jacoby. Also consists of a right held by Mr. Jacoby to purchase 246,479 shares currently held by a trustee. Also consists of 835,410 shares held by Odem Rotem Holdings Ltd., a company wholly-owned and controlled by Mr. Jacoby, and an option to purchase 380,994 shares held by Odem Rotem Holdings. The address of Mr. Jacoby is 22 Hanagar Street, Neve Ne’eman Industrial Zone B, Hod-Hasharon 45240, Israel. The address of Odem Rotem Holdings Ltd. and Anat Jacoby is 9 Nordau Street, Rannana, Israel.
|
|
(7)
|
Based on a Schedule 13G/A filed on February 14, 2008. Consists of 880,295 shares held by Gemini Israel II L.P., 690,669 shares held by Gemini Israel II Parallel Fund L.P., 112,216 shares held by Advent PGGM Gemini L.P. and 19,499 shares held by Gemini Partner Investors L.P. The board of directors of Gemini Israel Funds Ltd. has sole investment control with respect to these entities and is comprised of Steve Kahn, Amram Rasiel, Dr. A.I. (Ed) Mlavsky, Yossi Sela and David Cohen. These individuals share voting power over the shares and held by the Gemini entities and may be deemed to be the beneficial owners of the securities held thereby. Each individual disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The address of the Gemini entities and the foregoing individuals is 9 HaMenofim Street, Herzliya Pituach 46725, Israel.
|
|
|
Ÿ
|
two registrations at the request of one or more of our shareholders holding ordinary shares representing in the aggregate a majority of ordinary shares resulting from conversion of our Series A preferred shares, Series B preferred shares, collectively, referred to as the B Registrable Securities, and Series C preferred shares and all ordinary shares issued in respect of such shares;
|
|
|
Ÿ
|
one registration at the request of one of more of our shareholders holding ordinary shares representing in the aggregate a majority of ordinary shares resulting from conversion of our Series D preferred shares and all ordinary shares issued in respect of such shares;
|
|
|
Ÿ
|
one registration at the request of one of more of our shareholders holding ordinary shares representing in the aggregate a majority of ordinary shares resulting from conversion of our Series E preferred shares and all ordinary shares issued in respect of such shares; and
|
|
|
Ÿ
|
provided that (1) the aggregate proceeds from any such registration are estimated in good faith to be in excess of $5.0 million and (2) we are not required to effect a registration within 180 days after the effective date of our initial public offering or a registration statement for any subsequent offering.
|
|
Year
|
High
|
Low
|
||||||
|
2006
|
$ | 13.81 | $ | 10.10 | ||||
|
2007
|
11.5 | 4.35 | ||||||
|
2008
|
4.85 | 1.60 | ||||||
|
2009
|
4.25 | 1.42 | ||||||
|
2010
|
5.01 | 4.00 | ||||||
|
2008
|
||||||||
|
First Quarter
|
$ | 4.85 | $ | 2.24 | ||||
|
Second Quarter
|
3.54 | 2.50 | ||||||
|
Third Quarter
|
2.88 | 2.29 | ||||||
|
Fourth Quarter
|
2.45 | 1.60 | ||||||
|
2009
|
||||||||
|
First Quarter
|
$ | 1.80 | $ | 1.42 | ||||
|
Second Quarter
|
3.08 | 1.52 | ||||||
|
Third Quarter
|
4.20 | 3.00 | ||||||
|
Fourth Quarter
|
4.25 | 3.70 | ||||||
|
Most Recent Six Months
|
||||||||
| April 2010 | $ |
5.55
|
$ |
5.11
|
||||
|
March 2010
|
5.01 | 4.05 | ||||||
|
February 2010
|
4.22 | 4.00 | ||||||
|
January 2010
|
4.48 | 4.11 | ||||||
|
December 2009
|
4.13 | 3.72 | ||||||
|
November 2009
|
4.24 | 3.92 | ||||||
|
Material Contract
|
Location
|
|
|
Agreement with Flextronics (Israel) Ltd.
|
“ITEM 4.B: Information on the Company–Business Overview–Manufacturing.”
|
|
|
Agreement with R.H. Electronics Ltd.
|
“ITEM 4.B: Information on the Company–Business Overview–Manufacturing.”
|
|
|
Esphion Limited
|
“ITEM 5: Operating and Financial Review and Prospects–Operating Results–Overview.”
|
|
|
Second Amended and Restated Investor Rights Agreement
|
“ITEM 7. Major Shareholders and Related Party Transactions–Related Party Transactions–Registration Rights.”
|
|
|
Ÿ
|
The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;
|
|
|
Ÿ
|
The research and development must be for the promotion of the company; and
|
|
|
Ÿ
|
The research and development is carried out by or on behalf of the company seeking such tax deduction.
|
|
|
Ÿ
|
Amortization of the cost of purchased know-how and patents and of rights to use a patent and know-how which are used for the development or advancement of the company, over an eight-year period;
|
|
|
Ÿ
|
Accelerated depreciation rates on equipment and buildings;
|
|
|
Ÿ
|
Under specified conditions, an election to file consolidated tax returns with additional related Israeli Industrial Companies; and
|
|
|
Ÿ
|
Expenses related to a public offering in Israel and in recognized stock markets outside Israel, are deductible in equal amounts over three years.
|
|
|
Ÿ
|
Extension of the benefit period to up to ten years.
|
|
|
Ÿ
|
An additional period of reduced corporate tax liability at rates ranging between 10% and 25%, depending on the level of foreign (that is, non-Israeli) ownership of our shares. Those tax rates and the related levels of foreign investment are as set forth in the following table:
|
|
Rate of
Reduced Tax
|
Reduced Tax
Period
|
Tax Exemption
Period
|
Percent of
Foreign Ownership
|
|||
|
25
|
0 years
|
10 years
|
0-25%
|
|||
|
25
|
0 years
|
10 years
|
25-48.99%
|
|||
|
20
|
0 years
|
10 years
|
49-73.99%
|
|||
|
15
|
0 years
|
10 years
|
74-89.99%
|
|||
|
10
|
0 years
|
10 years
|
90-100%
|
|
Rate of
Reduced Tax
|
Reduced Tax Period |
Tax Exemption
Period
|
Percent of
Foreign Ownership
|
|||
|
25
|
1 years
|
6 years
|
0-25%
|
|||
|
25
|
4 years
|
6 years
|
25-48.99%
|
|||
|
20
|
4 years
|
6 years
|
49-73.99%
|
|||
|
15
|
4 years
|
6 years
|
74-89.99%
|
|||
|
10
|
4 years
|
6 years
|
90-100%
|
|
Rate of
Reduced Tax
|
Reduced Tax
Period
|
Tax Exemption
Period
|
Percent of
Foreign Ownership
|
|||
|
25
|
5 years
|
2 years
|
0-25%
|
|||
|
25
|
8 years
|
2 years
|
25-48.99%
|
|||
|
20
|
8 years
|
2 years
|
49-73.99%
|
|||
|
15
|
8 years
|
2 years
|
74-89.99%
|
|||
|
10
|
8 years
|
2 years
|
90-100%
|
|
|
Ÿ
|
The twelve years limitation period for reduced tax rate of 15% on dividend from the approved enterprise will not apply.
|
|
|
Ÿ
|
Similar to the currently available alternative route, exemption from corporate tax on undistributed income for a period of two to ten years, depending on the geographic location of the Benefited Enterprise within Israel, and a reduced corporate tax rate of 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in each year. Benefits may be granted for a term of seven to ten years, depending on the level of foreign investment in the company. If the company pays a dividend out of income derived from the Benefited Enterprise during the tax exemption period, such income will be subject to corporate tax at the applicable rate (10%-25%) in respect of the gross amount of the dividend that we may be distributed. The company is required to withhold tax at the source at a rate of 15% from any dividends distributed from income derived from the Benefited Enterprise; and
|
|
|
Ÿ
|
A special tax route, which enables companies owning facilities in certain geographical locations in Israel to pay corporate tax at the rate of 11.5% on income of the Benefited Enterprise. The benefits period is ten years. Upon payment of dividends, the company is required to withhold tax at source at a rate of 15% for Israeli residents and at a rate of 4% for foreign residents.
|
|
|
Ÿ
|
financial institutions or insurance companies;
|
|
|
Ÿ
|
real estate investment trusts, regulated investment companies or grantor trusts;
|
|
|
Ÿ
|
dealers or traders in securities or currencies;
|
|
|
Ÿ
|
tax-exempt entities;
|
|
|
Ÿ
|
certain former citizens or long-term residents of the United States;
|
|
|
Ÿ
|
persons that will hold our shares through a partnership or other pass-through entity;
|
|
|
Ÿ
|
persons that received our shares as compensation for the performance of services;
|
|
|
Ÿ
|
persons that will hold our shares as part of a “hedging” or “conversion” transaction or as a position in a “straddle” for United States federal income tax purposes;
|
|
|
Ÿ
|
persons whose “functional currency” is not the United States dollar; or
|
|
|
Ÿ
|
holders that own directly, indirectly or through attribution 10.0% or more of the voting power or value of our shares.
|
|
|
Ÿ
|
a citizen or resident of the United States;
|
|
|
Ÿ
|
corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof, including the District of Columbia;
|
|
|
Ÿ
|
an estate the income of which is subject to United States federal income taxation regardless of its source; or
|
|
|
Ÿ
|
a trust if such trust has validly elected to be treated as a United States person for United States federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its administration and (2) one or more United States persons have the authority to control all of the substantial decisions of such trust.
|
|
|
Ÿ
|
such gain is effectively connected with your conduct of a trade or business in the United States; or
|
|
|
Ÿ
|
you
are an individual and have been present in the United States for 183 days or more in the taxable year of such sale or exchange and certain other conditions are met.
|
|
|
Ÿ
|
at least 75 percent of its gross income is "passive income"; or
|
|
|
Ÿ
|
at least 50 percent of the average value of its gross assets (based on the quarterly value of such gross assets) is attributable to assets that produce “passive income” or are held for the production of passive income.
|
|
|
Ÿ
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
|
|
Ÿ
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors;
|
|
|
Ÿ
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
|
Year ended December, 31,
|
||||||||
|
2008
|
2009
|
|||||||
|
(in thousands of U.S. dollars)
|
||||||||
|
Audit Fees(1)
|
$ | 139 | $ | 127 | ||||
|
Audit-Related Fees(2)
|
40 | - | ||||||
|
Tax Fees(3)
|
35 | 42 | ||||||
|
All Other Fees(4)
|
49 | 31 | ||||||
|
Total
|
$ | 263 | $ | 200 | ||||
|
(1)
|
”Audit fees” include fees for services performed by our independent public accounting firm in connection with our annual audit for 2008 and 2009, certain procedures regarding our quarterly financial results submitted on Form 6-K and consultation concerning financial accounting and reporting standards.
|
|
(2)
|
“Audit-Related fees” include fees for the performance of due diligence investigations.
|
|
(3)
|
“Tax fees” include fees for professional services rendered by our independent registered public accounting firm for tax compliance and tax advice on actual or contemplated transactions.
|
|
(4)
|
“Other fees” include fees for services rendered by our independent registered public accounting firm with respect to government incentives.
|
|
|
Ÿ
|
We follow the requirements of Israeli law with respect to the quorum requirement for meetings of our shareholders, which are different from the requirements of Rule 5620(c). Under our articles of association, the quorum required for an ordinary meeting of shareholders consists of at least two shareholders present in person, by proxy or by written ballot, who hold or represent between them at least 25% of the voting power of our shares, instead of 33 1/3% of the issued share capital provided by under the NASDAQ Global Market requirements. This quorum requirement is based on the default requirement set forth in the Israeli Companies Law, 1999, or the Companies Law. We submitted a letter from our outside counsel in connection with this item prior to our initial public offering in November 2006.
|
|
|
Ÿ
|
We do not seek shareholder approval for equity compensation plans in accordance with the requirements of the Companies Law, which does not fully reflect the requirements of Rule 5635(c). Under Israeli law, we may amend our 2006 Incentive Compensation Plan by the approval of our board of directors, and without shareholder approval as is generally required under Rule 5635(c). Under Israeli law, the adoption and amendment of equity compensation plans, including changes to the reserved shares, do not require shareholder approval. We submitted a letter from our outside counsel in connection with this item in June 2008.
|
|
Allot Communications Ltd.
|
||
| By: /s/ Rami Hadar | ||
|
Rami Hadar
|
||
|
Chief Executive Officer and President
|
|
Number
|
Description
|
|
|
1.1
|
Articles of Association of the Registrant (1)
|
|
|
1.2
|
Certificate of Name Change (1)
|
|
|
2.1
|
Specimen share certificate (1)
|
|
|
2.2
|
Second Amended and Restated Investors Rights Agreement, dated October 26, 2006, by and among the parties thereto and the Registrant (1)
|
|
|
3.1
|
Escrow Agreement, dated January 28, 1998 by and among Yigal Jacoby, Ravillan Benzur & Co., Law Offices and the Registrant; Escrow Letter of Resignation and Appointment, dated January 31, 2004 by and among Yigal Jacoby, Yolovelsky, Dinstein, Sneh & Co. and the Registrant; and Assignment of Escrow Agreement, dated May 21, 2006 by and among Yodan Trust Company Ltd., Oro Trust Company Ltd., Yigal Jacoby and the Registrant (1)
|
|
|
3.2
|
Addendum, dated October 26, 2006, to Escrow Agreement, dated January 28, 1998, by and between Yigal Jacoby and the Registrant (1)
|
|
|
3.3
|
Addendum, dated November 13, 2008, to Escrow Agreement, dated January 28, 1998, by and between Yigal Jacoby and the Registrant (2)
|
|
|
4.1
|
Share Purchase Agreement, dated May 18, 2006, by and among the parties thereto and the Registrant (1)
|
|
|
4.2
|
Non-Competition Agreement, dated August 24, 2004, by and among Odem Rotem Holdings Ltd., Yigal Jacoby and the Registrant (1)
|
|
|
4.3
|
Experteam Training Services Proposal, dated as of March 2006, by Experteam to the Registrant (1)
|
|
|
4.4
|
Warrant to Purchase Series C-1 Shares, dated November 27, 2001, by and between the Company and Yigal Jacoby (1)
|
|
|
4.5
|
Manufacturing Agreement, dated September 4, 2002, by and between R.H. Electronics Ltd. and the Registrant* (1)
|
|
|
4.6
|
Non-Stabilized Lease Agreement, dated February 13, 2006, by and among, Aderet Hod Hasharon Ltd., Miritz, Inc., Leah and Israel Ruben Assets Ltd., Tamar and Moshe Cohen Assets Ltd., Drish Assets Ltd., S. L. A. A. Assets and Consulting Ltd., Iris Katz Ltd., Y. A. Groder Investments Ltd., Ginotel Hod Hasharon 2000 Ltd. and Allot Communications Ltd. (1)
|
|
|
4.7
|
Key Employees of Subsidiaries and Consultants Share Incentive Plan (1997) (1)
|
|
|
4.8
|
Key Employees Share Incentive Plan (1997) (1)
|
|
|
4.9
|
Key Employees Share Incentive Plan (2003) (1)
|
|
|
4.10
|
2006 Incentive Compensation Plan (2)
|
|
|
4.11
|
Manufacturing Agreement, dated July 19, 2007, by and between Flextronics (Israel) Ltd. and the Registrant* (3)
|
| Number | Description | |
|
4.12
|
Agreement relating to the sale and purchase of the Business and Assets dated January 1, 2008 by and between Esphion Limited and the Registrant(5)
|
|
|
8.1
|
List of Subsidiaries of the Registrant
|
|
|
11.1
|
Code of Ethics (4)
|
|
|
12.1
|
Certification of Principal Executive Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
12.2
|
Certification of Principal Financial Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
13.1
|
Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) and Rule 15d-14(b) (Section 906 Certifications)
|
|
|
14.1
|
Consent of Kost Forer Gabbay & Kasierer ( a member of Ernst & Young global)
|
|
|
14.2
|
Consent of Houlihan Smith & Company, Inc.
|
|
(1)
|
Previously filed with the Securities and Exchange Commission on October 31, 2006 pursuant to a registration statement on Form F-1 (File No. 333-138313) and incorporated by reference herein.
|
|
(2)
|
Previously filled with the Securities and Exchange Commission on May 27, 2009 as Exhibit 3.3 to Form 20-F for the year ended December 31, 2008 and incorporated by reference herein.
|
|
(3)
|
Previously filled with the Securities and Exchange Commission on June 27, 2008 as Exhibit 4.11 to Form 20-F for the year ended December 31, 2007 and incorporated by reference herein.
|
|
(4)
|
Previously filled with the Securities and Exchange Commission on June 28, 2007 as Exhibit 4 to Form 20-F for the year ended December 31, 2006 and incorporated by reference herein.
|
|
(5)
|
This document was furnished in accordance with SEC Release Nos. 33-8212 and 34-47551.
|
|
*
|
Portions of this exhibit were omitted and have been filed separately with the Secretary of the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act.
|
|
Page
|
|
|
F - 2
|
|
|
F - 3 - F - 4
|
|
|
F - 5
|
|
|
F - 6
|
|
|
F - 7 - F - 8
|
|
|
F - 9 - F - 35
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 67067, Israel
Tel:
972 (3)6232525
Fax: 972 (3)5622555
www.ey.com/il
|
| /s/ KOST FORER GABBAY & KASIERER | |
|
Tel-Aviv, Israel
|
KOST FORER GABBAY & KASIERER
|
|
April 8, 2010
|
A Member of Ernst & Young Global
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$ | 36,470 | $ | 40,029 | ||||
|
Restricted cash and deposits
|
1,060 | 1,058 | ||||||
|
Short-term bank deposits
|
1,264 | 1,063 | ||||||
|
Trade receivables (net of allowance for doubtful accounts of $ 253 and $ 180 at December 31, 2009 and 2008, respectively)
|
7,842 | 6,163 | ||||||
|
Other receivables and prepaid expenses
|
3,618
|
1,959 | ||||||
|
Inventories
|
5,046 | 4,259 | ||||||
|
Total
current assets
|
55,300
|
54,531 | ||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
14,490 | 15,319 | ||||||
|
Severance pay fund
|
3,410 | 3,402 | ||||||
|
Other assets
|
430 | 874 | ||||||
|
Total
long-term assets
|
18,330 | 19,595 | ||||||
|
PROPERTY AND EQUIPMENT, NET
|
5,674 | 4,970 | ||||||
|
GOODWILL AND INTANGIBLE ASSETS, NET
|
3,639 | 3,755 | ||||||
|
Total
assets
|
$ |
82,943
|
$ | 82,851 | ||||
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$ | 3,142 | $ | 2,902 | ||||
|
Employees and payroll accruals
|
3,930 | 3,324 | ||||||
|
Deferred revenues
|
5,467 | 4,475 | ||||||
|
Other payables and accrued expenses
|
4,582
|
3,142 | ||||||
|
Total
current liabilities
|
17,121
|
13,843 | ||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Deferred revenues
|
2,046 | 2,293 | ||||||
|
Accrued severance pay
|
3,364 | 3,536 | ||||||
|
Total
long-term liabilities
|
5,410 | 5,829 | ||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||
|
Share capital -
|
||||||||
|
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2009 and 2008; Issued: 22,643,541 and 22,313,596 shares at December 31, 2009 and 2008, respectively; Outstanding: 22,397,062 and 22,067,117 shares at December 31, 2009 and 2008, respectively
|
492 | 482 | ||||||
|
Additional paid-in capital
|
128,476 | 125,703 | ||||||
|
Accumulated other comprehensive income (loss)
|
(4,862 | ) | 697 | |||||
|
Accumulated deficit
|
(63,694 | ) | (63,703 | ) | ||||
|
Total
shareholders' equity
|
60,412 | 63,179 | ||||||
|
Total
liabilities and shareholders' equity
|
$ |
82,943
|
$ | 82,851 | ||||
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
$ | 29,641 | $ | 27,121 | $ | 25,073 | ||||||
|
Services
|
12,110 | 9,980 | 7,429 | |||||||||
|
Total
revenues
|
41,751 | 37,101 | 32,502 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
10,094 | 8,198 | 6,603 | |||||||||
|
Services
|
1,741 | 1,498 | 1,416 | |||||||||
|
Total
cost of revenues
|
11,835 | 9,696 | 8,019 | |||||||||
|
Gross profit
|
29,916 | 27,405 | 24,483 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development, net
|
9,265 | 11,964 | 9,384 | |||||||||
|
Sales and marketing
|
20,408 | 19,781 | 18,081 | |||||||||
|
General and administrative
|
5,541 | 6,174 | 5,583 | |||||||||
|
In-process research and development
|
- | 244 | - | |||||||||
|
Total
operating expenses
|
35,214 | 38,163 | 33,048 | |||||||||
|
Operating loss
|
(5,298 | ) | (10,758 | ) | (8,565 | ) | ||||||
|
Financial and other expenses, net
|
2,311 | 5,517 | 845 | |||||||||
|
Loss before income tax expenses
|
(7,609 | ) | (16,275 | ) | (9,410 | ) | ||||||
|
Income tax expenses
|
63 | 220 | 530 | |||||||||
|
Net loss
|
$ | (7,672 | ) | $ | (16,495 | ) | $ | (9,940 | ) | |||
|
Basic and diluted net loss per share
|
$ | (0.35 | ) | $ | (0.75 | ) | $ | (0.46 | ) | |||
|
Weighted average number of shares used in computing basic and diluted net loss per share
|
22,185,702 | 22,054,211 | 21,525,822 | |||||||||
|
Ordinary shares
|
Additional
paid-in
|
Deferred
stock
|
Accumulated other comprehensive
|
Accumulated
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
capital
|
compensation
|
income (loss)
|
deficit
|
Total
|
||||||||||||||||||||||
|
Balance at January 1, 2007
|
21,232,290 | $ | 456 | $ | 121,069 | $ | (34 | ) | $ | (36 | ) | $ | (37,268 | ) | $ | 84,187 | ||||||||||||
|
Exercise of warrants and employee stock options and repayment of non-recourse loan
|
1,022,438 | 24 | 1,448 | - | - | - | 1,472 | |||||||||||||||||||||
|
Expenses related to issuance of share capital upon Initial Public Offering
|
- | - | (58 | ) | - | - | - | (58 | ) | |||||||||||||||||||
|
Compensation related to options granted to non-employees
|
- | - | (172 | ) | - | - | - | (172 | ) | |||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 1,499 | 34 | - | - | 1,533 | |||||||||||||||||||||
|
Realized gain on available-for-sale securities
|
- | - | - | - | 36 | - | 36 | |||||||||||||||||||||
|
Tax benefit related to exercise of stock options
|
- | - | 127 | - | - | - | 127 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (9,940 | ) | (9,940 | ) | |||||||||||||||||||
|
Balance at December 31, 2007
|
22,254,728 | 480 | 123,913 | - | - | (47,208 | ) | 77,185 | ||||||||||||||||||||
|
Exercise of stock options
|
58,868 | 2 | 88 | - | - | - | 90 | |||||||||||||||||||||
|
Compensation related to options granted to non-employees
|
- | - | (198 | ) | - | - | - | (198 | ) | |||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 1,900 | - | - | - | 1,900 | |||||||||||||||||||||
|
Unrealized gain on hedging derivative instruments
|
- | - | - | - | 697 | - | 697 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (16,495 | ) | (16,495 | ) | |||||||||||||||||||
|
Balance at December 31, 2008
|
22,313,596 | 482 | 125,703 | - | 697 | (63,703 | ) | 63,179 | ||||||||||||||||||||
|
Exercise of stock options
|
329,945 | 10 | 475 | - | - | - | 485 | |||||||||||||||||||||
|
Compensation related to options granted to non-employees
|
- | - | 58 | - | - | - | 58 | |||||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 2,240 | - | - | - | 2,240 | |||||||||||||||||||||
|
Cumulative effect from adoption of ASC No. 320
|
- | - | - | - | (7,681 | ) | 7,681 | - | ||||||||||||||||||||
|
Unrealized loss on hedging derivative instruments
|
- | - | - | - | (85 | ) | - | (85 | ) | |||||||||||||||||||
|
Unrealized gain on marketable securities
|
- | - | - | - | 2,207 | - | 2,207 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (7,672 | ) | (7,672 | ) | |||||||||||||||||||
|
Balance at December 31, 2009
|
22,643,541 | $ | 492 | $ | 128,476 | $ | - | $ | (4,862 | ) | $ | (63,694 | ) | $ | 60,412 | |||||||||||||
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
$ | (7,672 | ) | $ | (16,495 | ) | $ | (9,940 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Depreciation
|
2,468 | 1,988 | 1,486 | |||||||||
|
Write-off of property and of equipment, net
|
385 | - | - | |||||||||
|
Stock-based compensation related to options granted to employees and non-employees
|
2,298 | 1,702 | 1,361 | |||||||||
|
In-process research and development
|
- | 244 | - | |||||||||
|
Amortization of intangible assets
|
116 | 119 | - | |||||||||
|
Capital loss (gain)
|
(108 | ) | 3 | 2 | ||||||||
|
Decrease (increase) in accrued severance pay, net
|
(180 | ) | 261 | 144 | ||||||||
|
Decrease in other assets
|
43 | 235 | 19 | |||||||||
|
Decrease (increase) in accrued interest and amortization of premium on marketable securities
|
2 | (27 | ) | (44 | ) | |||||||
|
Decrease in other long-term liabilities
|
- | - | (228 | ) | ||||||||
|
Decrease (increase) in trade receivables
|
(1,679 | ) | 20 | (1,944 | ) | |||||||
|
Decrease (increase) in other receivables and prepaid expenses
|
( 1,661 | ) | 2,564 | (1,798 | ) | |||||||
|
Increase in inventories, net
|
(787 | ) | (44 | ) | (1,154 | ) | ||||||
|
Decrease (increase) in long-term deferred taxes
|
316 | (101 | ) | 102 | ||||||||
|
Increase (decrease) in trade payables
|
240 | (507 | ) | (1,006 | ) | |||||||
|
Increase (decrease) in employees and payroll accruals
|
606 | (266 | ) | 980 | ||||||||
|
Increase in deferred revenues
|
745 | 1,396 | 1,684 | |||||||||
|
Increase (decrease) in other payables and accrued expenses
|
1,440
|
1,032 | (211 | ) | ||||||||
|
Other than temporary loss on marketable securities, net
|
3,036 | 7,700 | 4,881 | |||||||||
|
Net cash used in operating activities
|
(392 | ) | (176 | ) | (5,666 | ) | ||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Cash paid in connection with the acquisition of Esphion
|
- | (3,802 | ) | - | ||||||||
|
Increase in restricted cash and deposits
|
(2 | ) | (1,058 | ) | - | |||||||
|
Increase in short-term bank deposits
|
(201 | ) | (1,001 | ) | - | |||||||
|
Purchase of property and equipment
|
(3,608 | ) | (1,720 | ) | (3,466 | ) | ||||||
|
Proceeds from sale of property and equipment
|
159 | - | - | |||||||||
|
Investment in marketable securities
|
- | - | (87,134 | ) | ||||||||
|
Proceeds from redemption or sale of marketable securities
|
- | 19,595 | 115,751 | |||||||||
|
Net cash provided by (used in) investing activities
|
(3,652 | ) | 12,014 | 25,151 | ||||||||
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Bank credit repayment
|
- | - | (6 | ) | ||||||||
|
Exercise of stock options and repayment of non-recourse loan
|
485 | 90 | 1,436 | |||||||||
|
Excess tax benefit from stock-based compensation
|
- | - | 127 | |||||||||
|
Expenses related to issuance of share capital upon Initial Public offering
|
- | - | (58 | ) | ||||||||
|
Net cash provided by financing activities
|
485 | 90 | 1,499 | |||||||||
|
Increase (decrease) in cash and cash equivalents
|
(3,559 | ) | 11,928 | 20,984 | ||||||||
|
Cash and cash equivalents at the beginning of the year
|
40,029 | 28,101 | 7,117 | |||||||||
|
Cash and cash equivalents at the end of the year
|
$ | 36,470 | $ | 40,029 | $ | 28,101 | ||||||
|
Supplementary cash flow information:
|
||||||||||||
|
(a)
Non-cash activities:
|
||||||||||||
|
Exercise of options on account of other receivables
|
$ | - | $ | - | $ | 36 | ||||||
|
Increase in goodwill on account of earn out included in other liabilities and accrued expenses
|
$ | - | $ | 186 | $ | 140 | ||||||
|
(b)
Cash paid during the year for:
|
||||||||||||
|
Interest
|
$ | - | $ | 12 | $ | 1 | ||||||
|
Taxes
|
$ | 80 | $ | 69 | $ | 69 | ||||||
|
NOTE 1:-
|
GENERAL
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
|
e.
|
Restricted cash and deposits:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
%
|
||
|
Lab equipment
|
25-33
|
|
|
Computers and peripheral equipment
|
15-33
|
|
|
Office furniture
|
6-15
|
|
|
Leasehold improvements
|
By the shorter of term of the lease or the useful life of the asset
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Cost of revenues
|
$ | 104 | $ | 50 | $ | 48 | ||||||
|
Research and development
|
357 | 321 | 230 | |||||||||
|
Sales and marketing
|
775 | 465 | 340 | |||||||||
|
General and administrative
|
1,062 | 866 | 743 | |||||||||
|
Total
stock-based compensation expense
|
$ | 2,298 | $ | 1,702 | $ | 1,361 | ||||||
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Suboptimal exercise multiple
|
2.5-3.5 | 2 - 3.6 | 2-3 | |||||||||
|
Interest rate
|
0.31%-5.19 | % | 1.07%-6.81 | % | 3.18%-5.38 | % | ||||||
|
Volatility
|
53%-60 | % | 62% - 75 | % | 75 | % | ||||||
|
Dividend yield
|
0 | % | 0 | % | 0 | % | ||||||
|
Weighted-average fair value at grant date
|
1.27 | 2.46 | 8.57 | |||||||||
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
In May 2009, the FASB issued Accounting Standards Codification No. 855 (formerly, FASB Statement No. 165), "Subsequent Events" ("ASC No. 855"). This standard is intended to establish general standards of accounting for and disclosures of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. Specifically, this standard sets forth the period after the balance sheet date during which management of a reporting entity should evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements, the circumstances under which an entity should recognize events or transactions occurring after the balance sheet date in its financial statements, and the disclosures that an entity should make about events or transactions that occurred after the balance sheet date. ASC No. 855 is effective for fiscal years and interim periods ended after June 15, 2009. The Company adopted this standard effective June 15, 2009. The adoption of this guidance did not have a material effect on the consolidated financial statements.
|
|
|
1.
|
Provide updated guidance on whether multiple deliverables exist, how the deliverables in an arrangement should be separated, and how the consideration should be allocated;
|
|
|
2.
|
Require an entity to allocate revenue in an arrangement using estimated selling prices ("ESP") of deliverables if a vendor does not have vendor-specific objective evidence of selling price ("VSOE") or third-party evidence of selling price ("TPE"); and
|
|
|
3.
|
Eliminate the use of the residual method and require an entity to allocate revenue using the relative selling price method.
|
|
|
4.
|
Require expanded disclosures of qualitative and quantitative information regarding application of the multiple-deliverable revenue arrangement guidance.
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 3:-
|
ACQUISITIONS
|
|
Cash paid
|
$ | 3,500 | ||
|
Acquisition related transaction costs
|
302 | |||
|
Total
|
$ | 3,802 |
|
Tangible assets:
|
||||
|
Current assets
|
$ | 61 | ||
|
Property and equipment
|
49 | |||
|
Net tangible assets
|
110 | |||
|
Intangible assets:
|
||||
|
Core technology
|
726 | |||
|
In process research and development
|
244 | |||
|
Goodwill
|
2,722 | |||
|
Total assets acquired
|
$ | 3,802 | ||
|
NOTE 3:-
|
ACQUISITIONS (Cont.)
|
|
NOTE 4:-
|
MARKETABLE SECURITIES
|
|
December 31, 2009
|
December 31, 2008
|
|||||||||||||||||||||||
|
Carrying
|
Unrealized
|
Market
|
Carrying
|
Unrealized
|
Market
|
|||||||||||||||||||
|
value
|
gain
|
value
|
value
|
losses
|
value
|
|||||||||||||||||||
|
Auction rate securities(*)
|
$ | 12,283 | $ | 2,207 | $ | 14,490 | $ | 15,319 | $ | - | $ | 15,319 | ||||||||||||
|
|
(*)
|
ARS held by the Company are private placement securities with long-term nominal maturities for which the interest rates are reset through a "Dutch" auction each month. The monthly auctions historically have provided a liquid market for these securities. The Company's investments in ARS represent interests in collateralized debt obligations supported by pools of residential and commercial mortgages or credit cards, insurance securitizations and other structured credits. The ARS bear interest at rates ranging from 2.4% to 3.9% per annum.
|
|
NOTE 4:-
|
MARKETABLE SECURITIES (Cont.)
|
|
NOTE 4:-
|
MARKETABLE SECURITIES (Cont.)
|
|
Credit loss
|
||||
|
Balance as of April 1, 2009
|
$ | 6,058 | ||
|
Additional credit loss on debt securities for which other-than-temporary impairment was previously recognized
|
1,431 | |||
|
Reduction related to cash flow from expected to be collected
|
(809 | ) | ||
|
Balance as of December 31, 2009
|
$ | 6,680 | ||
|
NOTE 5:-
|
FAIR VALUE MEASUREMENTS
|
|
As of December 31, 2009
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Money market funds
|
$ | 15,358 | $ | - | $ | - | $ | 15,358 | ||||||||
|
Restricted deposit
|
- | 60 | - | 60 | ||||||||||||
|
Short-term deposits
|
- | 1,264 | - | 1,264 | ||||||||||||
|
Auction-rate securities
|
- | - | 14,490 | 14,490 | ||||||||||||
|
Foreign currency derivative contracts
|
- | 612 | - | 612 | ||||||||||||
|
Total financial assets
|
$ | 15,358 | $ | 1,936 | $ | 14,490 | $ | 31,784 | ||||||||
|
NOTE 5:-
|
FAIR VALUE MEASUREMENTS (Cont.)
|
|
As of December 31, 2008
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Money market funds
|
$ | 27,273 | $ | - | $ | - | $ | 27,273 | ||||||||
|
Restricted deposit
|
- | 1,058 | - | 1,058 | ||||||||||||
|
Short-term deposits
|
- | 1,063 | - | 1,063 | ||||||||||||
|
Auction rate securities
|
- | - | 15,319 | 15,319 | ||||||||||||
|
Foreign currency derivative contracts
|
- | 697 | - | 697 | ||||||||||||
|
Total financial assets
|
$ | 27,273 | $ | 2,818 | $ | 15,319 | $ | 45,410 | ||||||||
|
Marketable securities
|
||||||||
|
2009
|
2008
|
|||||||
|
Beginning balance
|
$ | 15,319 | $ | 35,371 | ||||
|
Capital gain from redemption of marketable securities
|
- | 5,346 | ||||||
|
OTTI on marketable securities*)
|
(3,036 | ) | (13,046 | ) | ||||
|
Redemption of marketable securities during the year
|
- | (12,352 | ) | |||||
|
Unrealized gain on marketable securities
|
2,207 | - | ||||||
|
Ending balance
|
$ | 14,490 | $ | 15,319 | ||||
|
|
*)
|
In 2009, part of this loss was reclassified to other comprehensive income in relation to the cumulative effect from accounting change as part of the adoption of ASC No. 320-10.
|
|
NOTE 6:-
|
INVENTORIES
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Raw materials
|
$ | 578 | $ | 550 | ||||
|
Finished products
|
4,468 | 3,709 | ||||||
| $ | 5,046 | $ | 4,259 | |||||
|
NOTE 7:-
|
PROPERTY AND EQUIPMENT
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Cost:
|
||||||||
|
Lab equipment
|
$ | 8,249 | $ | 6,983 | ||||
|
Computers and peripheral equipment
|
5,663 | 4,160 | ||||||
|
Office furniture and equipment
|
413 | 401 | ||||||
|
Leasehold improvements
|
497 | 406 | ||||||
| 14,822 | 11,950 | |||||||
|
Accumulated depreciation:
|
||||||||
|
Lab equipment
|
5,136 | 4,215 | ||||||
|
Computers and peripheral equipment
|
3,563 | 2,376 | ||||||
|
Office furniture and equipment
|
181 | 167 | ||||||
|
Leasehold improvements
|
268 | 222 | ||||||
| 9,148 | 6,980 | |||||||
|
Depreciated cost
|
$ | 5,674 | $ | 4,970 | ||||
|
NOTE 8:-
|
INTANGIBLE ASSETS, NET
|
|
a.
|
The following table shows the Company's intangible assets for the periods presented:
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Cost:
|
||||||||
|
Core technology (1)
|
$ | 726 | $ | 726 | ||||
|
Accumulated amortization
|
235 | 119 | ||||||
|
Amortized cost
|
$ | 491 | $ | 607 | ||||
|
|
(1)
|
Core technology was recorded in 2008 following the acquisition of the tangible and the intangible assets of Esphion. The Company amortizes the intangible assets using the straight-line method over a period of six years, which constitutes the number of years that approximate the pattern in which the economic benefits of the intangible assets will be consumed (see also Note 3).
|
|
b.
|
Amortization expenses for the years ended December 31, 2009, 2008 and 2007, were $ 116, $ 119 and $ 0, respectively.
|
|
NOTE 9:-
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
Year ended December 31,
|
||||
|
2010
|
$ | 1,122 | ||
|
2011
|
921 | |||
|
2012
|
849 | |||
|
2013
|
586 | |||
|
2014 and thereafter
|
113 | |||
| $ | 3,591 | |||
|
NOTE 9:-
|
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
|
c.
|
Lawsuit:
|
|
d.
|
Other: |
|
NOTE 10:-
|
SHAREHOLDERS' EQUITY
|
|
a.
|
Shares held in trust:
|
|
NOTE 10:-
|
SHAREHOLDERS' EQUITY (Cont.)
|
|
b.
|
Stock option plan:
|
|
Year ended December 31,
|
||||||||||||||||||||||||
|
2009
|
2008
|
2007
|
||||||||||||||||||||||
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
|||||||||||||||||||
|
Outstanding at beginning of year
|
4,069,505 | $ | 3.34 | 3,221,494 | $ | 4.42 | 3,383,930 | $ | 2.33 | |||||||||||||||
|
Granted
|
1,055,497 | $ | 3.05 | 1,299,150 | *) | $ | 2.46 | 989,249 | $ | 8.57 | ||||||||||||||
|
Forfeited
|
(713,374 | ) | $ | 6.46 | (392,271 | ) | $ | 7.49 | (169,381 | ) | $ | 5.37 | ||||||||||||
|
Exercised
|
(329,945 | ) | $ | 1.47 | (58,868 | ) | $ | 1.53 | (982,304 | ) | $ | 1.22 | ||||||||||||
|
Outstanding at end of year
|
4,081,683 | $ | 3.05 | 4,069,505 | $ | 3.54 | 3,221,494 | $ | 4.42 | |||||||||||||||
|
Exercisable at end of year
|
2,226,413 | $ | 3.12 | 2,050,911 | $ | 3.34 | 1,532,506 | $ | 4.42 | |||||||||||||||
|
|
*)
|
Including 11,800 restricted stock units ("RSUs") granted during 2008.
|
|
NOTE 10:-
|
SHAREHOLDERS' EQUITY (Cont.)
|
|
Exercise price
|
Shares upon exercise of options outstanding as of December 31, 2009
|
Weighted average remaining contractual life
|
Shares upon exercise of options exercisable as of December 31, 2009
|
|||||||||||
|
Years
|
||||||||||||||
| $ | 9.7-11.34 | 55,935 | 7.1 | 50,376 | ||||||||||
| $ | 7.45-9.25 | 78,662 | 7.2 | 57,841 | ||||||||||
| $ | 5.7-6.52 | 49,123 | 7.58 | 32,646 | ||||||||||
| $ | 4-4.62 | 395,434 | 8.32 | 155,245 | ||||||||||
| $ | 2.97-3.75 | 1,620,710 | 7.87 | 805,852 | ||||||||||
| $ | 2.05-2.49 | 1,702,519 | 7.17 | 1,013,470 | ||||||||||
| $ | 1.22-1.56 | 106,828 | 5.35 | 76,578 | ||||||||||
| $ | 0.009-0.03 | 72,472 | 7.47 | 34,405 | ||||||||||
| 4,081,683 | 2,226,413 | |||||||||||||
|
NOTE 10:-
|
SHAREHOLDERS' EQUITY (Cont.)
|
|
c.
|
The Company's outstanding warrants as of December 31, 2009, are as follows:
|
|
Issuance date
|
Number of shares to be issued
|
Class of shares
|
Exercise price per share
|
Exercisable through
|
||||||
|
January 1998 (*)
|
246,479 |
Ordinary shares
|
$ | 2.43 |
The earlier between a Liquidity Event and November 15, 2010
|
|||||
|
|
(*)
|
Granted to a Founder and a member of the Board of Directors who also served as Chief Executive Officer at the time of the grant. The underlying shares are issued and held in trust for the benefit of the Founder, pending his payment of the full purchase price of approximately $ 600. The Company does not consider these shares to be outstanding since, while these shares are held in trust neither the Founder nor the trustee has voting or economic rights with respect to such shares.
|
|
NOTE 11:-
|
TAXES ON INCOME
|
|
a.
|
Income Tax (Inflationary Adjustments) Law, 1985:
|
|
b.
|
Corporate tax rates:
|
|
c.
|
Tax benefits under Israel's law for the Encouragement of Capital Investments, 1959 ("the Law"):
|
|
NOTE 11:-
|
TAXES ON INCOME (Cont.)
|
|
d.
|
Tax benefits under the law for the Encouragement of Industry (taxes), 1969 ("the Encouragement Law"):
|
|
NOTE 11:-
|
TAXES ON INCOME (Cont.)
|
|
e.
|
Pre-tax loss is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Domestic
|
$ | (7,558 | ) | $ | (16,525 | ) | $ | (9,318 | ) | |||
|
Foreign
|
(51 | ) | 250 | (92 | ) | |||||||
| $ | (7,609 | ) | $ | (16,275 | ) | $ | (9,410 | ) | ||||
|
f.
|
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Loss before taxes on income
|
$ | (7,609 | ) | $ | (16,275 | ) | $ | (9,410 | ) | |||
|
Theoretical tax expense (benefit) computed at the statutory tax rate (26%, 27% and 29% for the years 2009, 2008 and 2007, respectively)
|
$ | (1,978 | ) | $ | (4,394 | ) | $ | (2,729 | ) | |||
|
Losses and temporary differences, net in respect of which no deferred taxes were recorded
|
1,738 | 3,811 | 2,207 | |||||||||
|
Taxes with respect to prior years
|
(189 | ) | (58 | ) | (1 | ) | ||||||
|
Change in expense associated with tax positions for current year
|
(210 | ) | 35 | - | ||||||||
|
Impairment of withholding tax asset
|
29 | 74 | 250 | |||||||||
|
Non-deductible expenses and other
|
70 | 265 | 181 | |||||||||
|
Non-deductible share-based compensation expenses
|
597 | 454 | 478 | |||||||||
|
Others
|
6 | 33 | 144 | |||||||||
|
Actual tax expenses
|
$ | 63 | $ | 220 | $ | 530 | ||||||
| Taxes on income are comprised as follows: | ||||||||||||
|
Current taxes
|
$ | 113 | $ | 343 | $ | 179 | ||||||
|
Deferred taxes
|
320 | (174 | ) | 102 | ||||||||
|
Taxes in respect of previous years
|
(189 | ) | (58 | ) | (1 | ) | ||||||
|
Change in expense associated with tax positions for current year
|
(210 | ) | 35 | - | ||||||||
|
Impairment of withholding tax asset
|
29 | 74 | 250 | |||||||||
| $ | 63 | $ | 220 | $ | 530 | |||||||
|
NOTE 11:-
|
TAXES ON INCOME (Cont.)
|
|
g.
|
Net operating losses carry forward:
|
|
h.
|
Deferred income taxes:
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating loss carry forward
|
$ | 11,070 | $ | 11,366 | ||||
|
Reserves and allowances
|
4,639 | 2,925 | ||||||
|
Deferred tax asset before valuation allowance
|
15,709 | 14,291 | ||||||
|
Valuation allowance
|
(15,559 | ) | (13,821 | ) | ||||
|
Net deferred tax asset
|
$ | 150 | $ | 470 | ||||
|
i.
|
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Beginning balance
|
$ | 285 | $ | 250 | ||||
|
Increase (decrease) in exposure associated with tax positions for current year
|
(210 | ) | 35 | |||||
|
Ending balance
|
$ | 75 | $ | 285 | ||||
|
NOTE 12:-
|
GEOGRAPHIC INFORMATION
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Europe
|
$ | 18,735 | $ | 12,221 | $ | 10,496 | ||||||
|
Asia and Oceania
|
11,004 | 11,235 | 9,874 | |||||||||
|
United States of America
|
6,316 | 7,582 | 6,435 | |||||||||
|
Middle East and Africa
|
2,992 | 2,752 | 2,061 | |||||||||
|
Americas (excluding United States of America)
|
2,704 | 3,311 | 3,636 | |||||||||
| $ | 41,751 | $ | 37,101 | $ | 32,502 | |||||||
|
December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
Long-lived assets:
|
||||||||
|
Israel
|
$ | 9,270 | $ | 8,910 | ||||
|
United States of America
|
300 | 114 | ||||||
|
Other
|
173 | 210 | ||||||
| $ | 9,743 | $ | 9,234 | |||||
|
NOTE 13:-
|
FINANCIAL AND OTHER EXPENSES, NET
|
|
Year ended December 31,
|
||||||||||||
|
2009
|
2008
|
2007
|
||||||||||
|
Financial and other income:
|
||||||||||||
|
Interest income
|
$ | (914 | ) | $ | (2,571 | ) | $ | (4,193 | ) | |||
|
Financial and other expenses:
|
||||||||||||
|
Interest expenses (income) and other miscellaneous
|
(17 | ) | 335 | 79 | ||||||||
|
Foreign currency transactions differences
|
206 | 53 | 78 | |||||||||
|
Impairment related to Auction-Rate Securities, net
|
3,036 | 7,700 | 4,881 | |||||||||
| $ | 2,311 | $ | 5,517 | $ | 845 | |||||||
|
NOTE 14:-
|
DERIVATIVE INSTRUMENTS
|
|
Foreign exchange forward and
|
As of December 31,
|
|||||||||
|
options contracts
|
Balance Sheet
|
2009
|
2008
|
|||||||
|
Fair Value of foreign exchange option contracts
|
"Other receivables and prepaid expenses"
|
$ | 24 | $ | 13 | |||||
|
Fair value of foreign exchange forward contracts
|
588 | 684 | ||||||||
|
Total
|
$ | 612 | $ | 697 | ||||||
|
Increase (decrease) in gains recognized in OCI (effective portion)
|
"Other comprehensive income"
|
$ | (85 | ) | $ | 697 | ||||
|
NOTE 14:-
|
DERIVATIVE INSTRUMENTS (Cont.)
|
|
Foreign exchange forward and
|
Statements of
|
Year ended December 31,
|
||||||||
|
options contracts
|
Operations
|
2009
|
2008
|
|||||||
|
Gain on derivatives recognized in OCI
|
"Operating expenses"
|
$ | 298 | $ | - | |||||
|
Gain (loss) recognized in income on derivatives (effective portion)
|
"Operating expenses"
|
$ | 383 | $ | (230 | ) | ||||
|
NOTE 15:-
|
SUBSEQUENT EVENTS
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|